In Motion Physical Therapy Joins PE-Backed Ivy Rehab
Private equity-backed Ivy Rehab announced in January 2025 that it has partnered with In Motion Physical Therapy in Downingtown, Pennsylvania. Financial terms of the deal were not disclosed. In Motion Physical Therapy is a provider of outpatient physical therapy in Pennsylvania. The company is led by a team of therapists specializing in orthopedics, spine rehabilitation and manual therapy. Founded in 2003, Ivy Rehab, a portfolio company of middle-market private equity firm Waud Capital Partners, is a network of outpatient physical, occupational and speech therapy and applied behavior analysis clinics throughout the United States. “We are thrilled to welcome In Motion... Read More »
West Physics Consulting Acquires Mid-South Medical Physics in Arkansas
West Physics Consulting announced on January 13 that it has entered into a strategic partnership agreement with Mid-South Medical Physics. The partnership with Mid-South includes a multi-phase acquisition of Mid-South by West Physics, allowing Mid-South’s owner and President, Mr. Paul Beck, to gradually retire as West Physics supports him and his customers with services and expertise. Founded in 2003, Mid-South Medical Physics is a medical and health physics services provider based in West Fork, Arkansas. The company provides its services to clients throughout Arkansas and northern Louisiana. West Physics is a global provider of medical and health physics testing and radiation safety... Read More »
Heartland Dental Acquires Garners Ferry Dentistry
On January 10, Heartland Dental announced its first acquisition of 2025 with the purchase of Garners Ferry Dentistry. Garners Ferry Dentistry is a dental practice with one location in Columbia, South Carolina. The practice is led by Anna Fuller, DMD. Services offered include general dentistry, pediatric dentistry, extractions, dentures and root canals. Heartland Dental is a dental support organization providing non-clinical, administrative support services with more than 2,600 doctors in more than 1,650 locations across 38 states. The company is majority-owned by KKR, a global investment firm. This transaction expands Heartland Dental’s presence in South Carolina. The... Read More »
Northlane Capital Partners Acquires United States Drug Testing Laboratories
Brown Gibbons Lang & Company, a middle market investment bank, announced the acquisition of United States Drug Testing Laboratories Inc. (USDTL) by Northlane Capital Partners (NCP). USDTL provides substance abuse toxicology services worldwide for healthcare facilities, child protection agencies, the Department of Defense, legal services, research, businesses and analytical/forensic laboratories. USDTL has more than 160 employees serving more than 1,000 customers in the United States and internationally. Founded in 2003, NCP manages a $1 billion private equity fund investing in control buyouts of middle market companies based in North America. It looks for platform... Read More »
Cube Biotech Acquires IBA Lifesciences
Cube Biotech, a portfolio company of private equity firm Archimed, announced on January 14 that it entered into an agreement to acquire IBA Lifesciences. IBA Lifesciences is a biotechnology company providing products and custom specific services for life science applications in academia and industry worldwide. It is based in Goettingen, Germany and was founded in 1996. Backed by Archimed since 2021, Cube Biotech is a biotechnology company based in Monheim, Germany. It is a provider of solutions for protein purification, stabilization and structural studies. The combination of the two companies will leverage their complementary strengths to deliver solutions in protein... Read More »
Economic and Election Uncertainty Slows 2024 Physician Group M&A Activity
The Physician Medical Group (PMG) sector experienced a decline in deal volume throughout the year. In 2024, 473 PMG deals were announced, a 12% decline from the 537 PMG deals announced in 2023 and a 24% decrease from the 622 deals reported in 2022. In the fourth quarter of 2024, there were 101 PMG deals, which is the slowest quarter for the year. Some advisors that the LevinPro HC team has spoken to throughout the year have noted several significant factors contributing to the decline in PMG deal volume. Common themes that advisors cited were uncertainty surrounding the election, an unstable economy, higher interest rates and even heightened scrutiny surrounding private equity... Read More »
Branford Castle Expands In New Jersey
Branford Castle announced its first acquisition of 2025 with the purchase of Eastern Dental Management for an undisclosed price. The seller was Staple Street Capital, a private investment firm. Eastern Dental Management is a dental service organization (DSO) based out of 20 locations across New Jersey. It was founded more than 30 years ago. Branford Castle is a New York-based private equity firm focused on lower middle-market investments, with more than 35 years of helping to grow businesses. The company typically makes control investments in companies with up to $15 million of EBITDA and a leadership position in a niche industry. Branford Castle was advised by its legal... Read More »
Health Catalyst Acquires Upfront Healthcare Services for $86 Million
On January 13, Health Catalyst, Inc. announced that it was acquiring Upfront Healthcare Services. According to Health Catalyst’s 8-K SEC filing, Upfront is being acquired for approximately $86 million and potential additional aggregate consideration of approximately $33.4 million. Upfront is a patient engagement platform provider based in Chicago. Upfront provides a patient activation and engagement platform and a proprietary strategic marketing analytics and content personalization solution for healthcare enterprises. Its automated patient acquisition and retention solutions enable healthcare organizations to build loyalty and guide patients to optimal care by leveraging... Read More »
PwC’s Behind the Numbers of Medical Costs
PwC’s Health Research Institute published an article in early January 2025 that projects commercial healthcare spending growth will hit a 13-year high in 2025, with an 8% increase in the Group market and 7.5% in the Individual market. This is driven by inflation, the rising cost of prescription drugs and increased behavioral health utilization. Updated 2023 and 2024 trends reveal higher-than-expected costs due to increased use of GLP-1 drugs and deferred pandemic care. While cost-saving measures like biosimilars offer some relief, they do not counter the increasing expenses. The report highlights the need for healthcare organizations to develop strategies that balance cost... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
